COMPANY
Coologics
Funding and NIH signals
- SEC Form D raise Raised $1M (Form D filed Sep 10, 2026). SEC Form D 0002150705-26-000001 (Sep 10, 2026)
Evidence (1 event)
- Sep 10, 2026 · SEC Form D 0002150705-26-000001
Name of Issuer: Coologics, Inc.; CIK: 2150705; Address: Grove City, OH; Submission type: D; Filing date: 2026-09-10; Industry Group: Other; Date of First Sale: 2026-09-01; Types of Securities Offered: Other (Simple Agreement for Future Equity (SAFE)); Business combination transaction: false; Total Offering Amount: 2500000; Total Amount Sold: 1000000; Federal exemptions: 06b
- Sep 10, 2026 · SEC Form D 0002150705-26-000001
Timeline
- Trial start Not phased (device or behavioral study): Clinical Study of a Vaginal Cooling Device for the Treatment of Vulvovaginal Candidiasis (VVC) source ↗
Clinical trials (lead sponsor) 1
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT06983041 | Clinical Study of a Vaginal Cooling Device for the Treatment of Vulvovaginal Candidiasis (VVC) | Not phased (device or behavioral study) | Recruiting | May 22, 2025 | Jun 30, 2026 (estimated) |